Abstract Details

Title Improvements in Quality of Life Over 6 Years in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab: Results From the CARE-MS II Extension Study

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 342

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rafael Arroyo Gonzalez PRESENTER	Rafael Arroyo Gonzalez has nothing to disclose.
David H. Margolin, MD, PhD (Genzyme Corporation)	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jennifer Guo (Sanofi)	No disclosure on file
David Cella, PhD (Northwestern Feinberg School of Medicine)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��